Last checked at 
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.
----------
AIM - WINNERS
----------
Windar Photonics PLC, up 67% at 13.20 pence, 12-month range 5.10p-21.00p. The wind sensor developer notes the suspension of its shares from trading on AIM has been lifted. Its shares were suspended due to a delay to its financial results. In its now-published results, the firm reports a pretax loss of EUR880,317 in the six months ended June 30, narrowed from EUR962,340 the previous year. Revenue in the period rises to EUR420,555 from EUR305,991. In its delayed full-year results, the company reports a narrowed pretax loss of EUR1.4 million in 2021, from a loss of EUR1.6 million the previous year. Contract revenue in 2021 drops sharply to EUR551,535 from EUR1.3 million year-on-year.
----------
C4X Discovery Holdings PLC, up 37% at 28.00 pence, 12-month range 18.02p-47.90p. Signs an exclusive worldwide licensing agreement with Cambridge-based pharmaceutical firm AstraZeneca PLC worth up to USD402 million for its NRF2 activator programme. AstraZeneca will develop and commercialise an oral therapy for the treatment of inflammatory and respiratory diseases with a focus on chronic obstructive pulmonary disease. C4XD will receive pre-clinical milestone payments worth up to USD16 million ahead of the first clinical trial, including USD2 million upfront. In addition, the drug discovery firm is eligible to receive a further USD385.8 million in clinical development and commercial milestones and tiered mid-single digit royalties upon commercialisation.
----------
AIM - LOSERS
----------
Inspiration Healthcare Group PLC, down 33% at 56.50 pence, 12-month range 53.50p-133.00p. Since its last statement, the medical technology firm says it has continued to win "substantial" orders for its products, particularly in Ukraine and Thailand. However, says that the timing of receiving and shipping these orders has been "hard to predict" due to continuing economic uncertainty. As a result, it is now believed that it is "unlikely" that sales for the full-year will exceed those of last year. In addition, the firm's earnings before interest, tax, depreciation and amortisation are now expected to be below that of the first half.
----------
Induction Healthcare Group PLC, down 13% at 31.90 pence, 12-month range 31.00p-68.00p. In the year ended March 31, the digital health platform reports a pretax loss of GBP9.6 million, widened from GBP8.1 million the previous year. Revenue from contracts with customers, meanwhile, jumps to GBP7.9 million from GBP1.4 million year-on-year. The figure is unable to offset a surge in expenses, however. Sales and marketing expenses leap to GBP1.2 million from GBP590,000, administrative expenses rise to GBP7.3 million from GBP4.9 million, and development expenses surge to GBP6.0 million from GBP1.9 million.
----------
By Heather Rydings; heatherrydings@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.
